[1]
Sotiriou, E. et al. 2022. Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre. Dermatology Practical & Conceptual. 12, 2 (May 2022), e2022076. DOI:https://doi.org/10.5826/dpc.1202a76.